Skip to main content
Caplight Logo









Mymee

Mymee

Private
New York City, New YorkHealthcare & Life Scienceshttps://mymee.com

Last Round

Series A

Feb 11, 2021

Total Funding Raised

$8.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mymee operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in February 2021.

Mymee is a digital health company that provides a personalized care platform to help patients with autoimmune diseases and long COVID identify and manage health triggers.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Precision Medicine, Telemedicine, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Mymee Comparables

Compare Mymee with similar companies based on industry and business-model similarity.

Mymee comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WellTheory
86%
ViuHealth
83%
Motto Health
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Mymee Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 11, 2021
SeedSep 7, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Mymee Investors

Notable investors and investment history

Mymee investors
InvestorRounds
Plug and Play Tech CenterSeries A
MedStartrSeries A
DreamitSeed, Series A
Capita3Series A
New York VenturesSeries A
Half Court VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 776% MoM, reaching 9.5K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Mymee Filings

Explore SEC and related filing metadata, where available.

Mymee filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Mymee's valuation, stock price, and market status.

Is Mymee a public or private company?

Mymee is a private company.

What is the current stock price of Mymee?

Mymee is a private company, so its shares have no public market price. Caplight tracks Mymee's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Mymee worth (valuation)?

Valuation information for Mymee is not publicly available.

Can I buy Mymee stock?

Mymee shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Mymee's last funding round?

Mymee's most recent funding round was Series A on February 11, 2021.

Who are the main investors in Mymee?

Key investors in Mymee include New York Ventures.

Will Mymee IPO soon?

No public IPO plans have been announced for Mymee.

How can I track Mymee secondary market activity?

Caplight tracks bids, offers, and trades in Mymee's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range5
Year Founded2017
Last FundingFeb 11, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?